Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Martin Andreas Proescholdt"'
Autor:
Tobias Mederer, Sebastian Schachinger, Katharina Rosengarth, Anja Brosig, Karl-Michael Schebesch, Christian Doenitz, Nils-Ole Schmidt, Martin Andreas Proescholdt
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeNon-skull base meningiomas (NSBM) are a distinct entity and frequently present with focal neurological deficits. This study was designed to analyze functional and oncological outcome following microsurgical tumor resection in patients with NSB
Externí odkaz:
https://doaj.org/article/7a00c3632e1c4fddb4ac581a839c1d5e
Autor:
Raquel Blazquez, Martin Andreas Proescholdt, Marlene Klauser, Karl-Michael Schebesch, Christian Doenitz, Daniel Heudobler, Lena Stange, Markus J. Riemenschneider, Elisabeth Bumes, Katharina Rosengarth, Andreas Schicho, Nils-Ole Schmidt, Alexander Brawanski, Tobias Pukrop, Christina Wendl
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeBrain metastases (BM) can present a displacing or infiltrating growth pattern, independent of the primary tumor type. Previous studies have shown that tumor cell infiltration at the macro-metastasis/brain parenchyma interface (MMPI) is correla
Externí odkaz:
https://doaj.org/article/01a46bbf606d44e7909524e0830c4620
Autor:
Elisabeth, Bumes, Claudia, Fellner, Franz A, Fellner, Karin, Fleischanderl, Martina, Häckl, Stefan, Lenz, Ralf, Linker, Tim, Mirus, Peter J, Oefner, Christian, Paar, Martin Andreas, Proescholdt, Markus J, Riemenschneider, Katharina, Rosengarth, Serge, Weis, Christina, Wendl, Sibylle, Wimmer, Peter, Hau, Wolfram, Gronwald, Markus, Hutterer
Publikováno v:
Cancers. 14(11)
The
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 5, Pp 8708-8718 (2013)
Brain metastases (BM) develop in about 30% of all cancer patients. Surgery plays an important role in confirming neuropathological diagnosis, relieving mass effects and improving the neurological status. To select patients with the highest benefit fr
Publikováno v:
International Journal of Molecular Sciences
Brain metastases (BM) develop in about 30% of all cancer patients. Surgery plays an important role in confirming neuropathological diagnosis, relieving mass effects and improving the neurological status. To select patients with the highest benefit fr